Edwards Lifesciences Corp...

NYSE: EW · Real-Time Price · USD
77.89
-0.29 (-0.37%)
At close: Aug 15, 2025, 9:58 AM

Edwards Lifesciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
4.17B 1.4B 1.52B 1.5B
Depreciation & Amortization
155.2M 144.9M 139.6M 134.8M
Stock-Based Compensation
162.3M 139.4M 126.8M 109.3M
Other Working Capital
-213.9M -242.1M -102.5M 43.5M
Other Non-Cash Items
-3.36B 7.5M 105.8M -119M
Deferred Income Tax
-323.4M -272.1M -254.5M -41.4M
Change in Working Capital
-259.3M -526.3M -421.4M 145.3M
Operating Cash Flow
542.3M 895.8M 1.22B 1.73B
Capital Expenditures
-252.4M -266.3M -264.8M -329.8M
Cash Acquisitions
-1.06B -95.2M n/a 329.8M
Purchase of Investments
-945.8M -105.5M -778.9M -1.89B
Sales Maturities Of Investments
857.6M 715.8M 1.36B 529.2M
Other Investing Acitivies
3.75B -75M -63.1M -359.3M
Investing Cash Flow
2.31B 173.8M 252.3M -1.72B
Debt Repayment
n/a -300K -200K -1.8M
Common Stock Repurchased
-1.16B -879.6M -1.73B -512.8M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
176.4M 168.9M 142.8M 158.3M
Financial Cash Flow
-983M -711M -1.58B -356.3M
Net Cash Flow
1.91B 375.4M -94.8M -332.8M
Free Cash Flow
289.9M 629.5M 953.4M 1.4B